Skip to main content
SpringerLink
Log in

Solubility enhancement of cox-2 inhibitors using various solvent systems

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

This study examined the solubility enhancement of 4 cox-2 inhibitors, celecoxib, rofecoxib, meloxicam, and nimesulide, using a series of pure solvents and solvent mixtures. Water, alcohols, glycols, glycerol, and polyethylene glycol 400 (PEG 400) were used as solvents and water-ethanol, glycerol-ethanol, and polyethylene glycol-ethanol were used as mixed-solvent systems. A pH-solubility profile of drugs was obtained in the pH range 7.0 to 10.9 using 0.05M glycine-sodium hydroxide buffer solutions. Lower alcohols, higher glycols, and PEG 400 were found to be good solvents for these drugs. The aqueous solubility of celecoxib, rofecoxib, and nimesulide could be enhanced significantly by using ethanol as the second solvent. Among the mixed-solvent systems, PEG 400-ethanol system had highest solubilization potential. In the case of meloxicam and nimesulide, solubility increased significantly with increase in pH value. Physico-chemical properties of the solvent such as polarity, intermolecular interactions, and the ability of the solvent to form a hydrogen bond with the drug molecules were found to be the major factors involved in the dissolution of drugs by pure solvents. The greater the difference in the polarity of the 2 solvents in a given mixed solvent, the greater was the solubilization power. However, in a given mixed-solvent system, the solubilization power could not be related to the polarity of the drugs. Significance of the solubility data in relation to the development of formulations has also been discussed in this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lane NE, Thompson JM. Management of osteoarthritis in the primary-care setting: an evidence-based approach to treatment. Am J Med. 1997;103(6A):25–35.

    Article  Google Scholar 

  2. Needleman P, Isakson PC. The discovery and function of cox-2. J Rheumatol. 1997;24(suppl 49):6–8.

    Google Scholar 

  3. Bolten WW. Scientific rationale for specific inhibition of cox-2. J Rheumatol. 1998;25(suppl 51):2–7.

    Google Scholar 

  4. Depre M, Ehrich E, Van Hecken A, De Lepeleire I, Dallob A, Wong P, Porras A, Gertz BJ, De Schepper PJ. Pharmacokinetics, cox-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans. Eur J Clin Pharmacol. 2000;56:167–174.

    Article  CAS  Google Scholar 

  5. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A. 1992;89:7384–7388.

    Article  CAS  Google Scholar 

  6. Silas S, Clegg DO. Selective cox-2 inhibition. Bull Rheum Dis. 1999,40(2):1–4.

    Google Scholar 

  7. Ran Y, Zhao L, Xu Q, Yalkowsky H. Solubilization of cyclosporin A. AAPS PharmSciTech. 2001;2(1) article 2.

  8. Yalkowsky SH, Roseman TJ. Solubilization of drugs by cosolvents. In: Yalkowsky SH, ed. Techniques of Solubilization of Drugs. Vol 12. New York, NY: Marcel Dekker Inc; 1981:91–134.

    Google Scholar 

  9. Zhao L, Li P, Yalkowsky SH. Solubilization of fluasterone. J Pharm Sci. 1999;88:967–969.

    Article  CAS  Google Scholar 

  10. Vavia PR, Adhage NA. Inclusion complexation of nimesulide with ∃-cyclodextrins. Drug Dev Ind Pharm. 1999;25:543–545.

    Article  CAS  Google Scholar 

  11. Piel G, Pirotte B, Delneuville I, Neven P, Llabres G, Delarge J, Delattre L. Study of the influence of both cyclodextrins and L-lysine on the aqueous solubility of nimesulide; isolation and characterization of nimesulide-L-lysin-cyclodextrin complexes. J Pharm Sci. 1997;86:475–480.

    Article  CAS  Google Scholar 

  12. Chowdary KPR, Hymavathi R. Enhancement of dissolution rate of meloxicam. Indian J Pharm Sci. 2001;63(2):150–154.

    Google Scholar 

  13. Baboota S, Agarwal SP. Inclusion complexes of meloxicam with ∃-cyclodextrin. Indian J Pharm Sci. 2002;64(4):408–411.

    CAS  Google Scholar 

  14. Wilkinson SG. Alcohols. In: Stoddart JF, ed. Comprehensive Organic Chemistry. Vol. 1. New York, NY: Pergamon Press, 1979;579–706.

    Google Scholar 

  15. Li P, Zhao L, Yalkowsky SH. Combined effect of cosolvent and cyclodextrin on solubilization of non-polar drugs. J Pharm Sci. 1999;88:1107–1111.

    Article  CAS  Google Scholar 

  16. Yalkowski SH, Rubino JT. Solubilization of cosolvents 1: organic solutes in propylene glycol-water mixtures. J Pharm Sci. 1985;74:416–421.

    Article  Google Scholar 

  17. Etman MA, Salama RO, Shamsedeen MA, El-Kamal A. Indian. J Pharm Sci. 2001;63(6):459–467.

    Google Scholar 

  18. Millard JW, Alvarez-Nunez FA, Yalkowsky SH. Int J Pharm. 2002;245:153–166.

    Article  CAS  Google Scholar 

  19. Krishna G, Hodnick WF, Lang W, Lin X, Karra S, Mao J, Almassian B. Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP 40101M. AAPS PharmSciTech 2001;2(3) article 14.

  20. Powell M, Nguyen T, Baloian L. Compendium of excipients for parenteral formulations. PDA J Pharm Sci Technol. 1998;52:238–311.

    CAS  Google Scholar 

  21. Mottu F, Laurent A, Rufenacht D, Doelker E. Organic solvents for pharmaceutical parenterals and embolic liquids: a review of toxicity data. PDA J Pharm Sci Technol. 2000;54:456–469.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemistry, Panjab University, 160014, Chandigarh, India

    Neelam Seedher & Sonu Bhatia

Authors
  1. Neelam Seedher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sonu Bhatia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Neelam Seedher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seedher, N., Bhatia, S. Solubility enhancement of cox-2 inhibitors using various solvent systems. AAPS PharmSciTech 4, 33 (2003). https://doi.org/10.1208/pt040333

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt040333

Keywords

Search

Navigation